Patient Assistance Programs:
Essential Patient Access to Vital Medicines
Recently, some health care analysts have broadly criticized patient assistance programs (PAPs) as a significant cause of growth in prescription drug spending and overall health care costs. In a new paper, NORD addresses this issue and explains the essential function of PAPs for people with rare diseases.
